EEF2 and cancer: Although numerous compounds have been discovered to inhibit eEF2-related molecular signaling and enhance its phosphorylation level in different cancer cells, there is a scarcity of reported inhibitors that directly target eEF2 or its associated complexes [64, 109, 110].